In a breakthrough development, Ayala Pharmaceuticals (OTCQX: ADXS) recently announced the successful completion of an end-of-Phase 2 meeting with the U.S. Food and Drug Administration…
Precision diagnostics company, Oncocyte Corporation (Nasdaq: OCX), is addressing a market of more than one million annual testing opportunities in the United States as it…
On the heels of Biogen’s 2022 success with Aduhelm in 2021 and lecanemab in early 2023, the neuroscience space has become increasingly crowded with drug…
Four Next-Gen Sectors to Watch
Next-Gen stocks – companies in innovative growth sectors including biotechnology, renewable energy, AI, blockchain technology, electric vehicles (EV), and others – are attracting the attention…
As investors examine sectors and opportunities for timely investments, energy is always of interest. The S&P finished 2022 with record gains in its energy sector…
Prism MarketView Market Insights: What’s Ahead This Week
Investors are settling into a week with anticipation for the latter half as they tee up for a big macro week coupled with a kickoff…
Lipella Pharmaceuticals Reports 2022 Earnings; Completes Initial Public Offering, Achieves Key Milestones
Clinical stage biotechnology company, Lipella Pharmaceuticals (Nasdaq: LIPO), has reported its 2022 financial results and provided a business update.
OpenLocker (OLKR) Creates “FanTech” Opportunity for Fans and Student-Athletes of FAU and UConn
All eyes of college sports fanatics were tuned into the Elite Eight round of the March Madness NCAA Men’s Basketball tournament, this weekend. Now, only…
SuperCom Ltd. (SPCB) is a global provider of secured solutions for the e-Government, IoT, and Cybersecurity sectors. SuperCom presents an impressive group of experts in…
A Pivotal Year Ahead for Quoin Pharmaceuticals
Company celebrates key milestones and charts path from clinical-stage to commercial. Since commencing trading on Nasdaq in October 2021, Quoin Pharmaceuticals ( Nasdaq: QNRX )…
The skin is the body’s largest organ, a barrier protecting us from infectious agents and allergens and preventing water loss. Its healthy functioning is critical…
Bionik Eyes $4.9 Billion Global Neurorehabilitation Devices Market with New Strategic Direction
Robotics and neurological recovery solutions company Bionik Laboratories (OTCPINK: BKNL), has unveiled a new strategic approach to rehabilitating stroke survivors and others with functional and mobility…





